Home

overview

Congenital adrenal hyperplasia (CAH) presents complex, lifelong challenges that impact patients' quality of life—from growth suppression in children to long-term metabolic and psychological effects. This symposium offers clinicians a unique opportunity to build confidence in managing CAH, especially amid the emergence of innovative therapies that may reduce reliance on glucocorticoids. Gain insights into timely diagnosis, individualized treatment strategies, and optimizing care during critical transitions such as puberty and adulthood. [break][break] Join us to explore cutting-edge advances and improve outcomes for pediatric and adolescent patients living with this rare, often misunderstood condition. Empower your practice with the latest in CAH management.

faculty

CHAIR

Richard J. Auchus, MD, PhD, FACE

The James A. Shayman and Andrea S. Kevrick Professor of Translational Medicine

Division of Metabolism, Endocrinology, and Diabetes

Departments of Internal Medicine

and Pharmacology

University of Michigan Medical School

Ann Arbor, Michigan

SPEAKER

Patricia Y. Fechner, MD

Professor of Pediatrics

University of Washington School of Medicine

Medical Director

Seattle Children's CAH Center of Excellence

Seattle, Washington

SPEAKER

Phyllis W. Speiser, MD

Emeritus Professor of Pediatrics

Zucker School of Medicine at Hofstra/Northwell

Hempstead, New York

AGENDA

12:00 PM TZ

Welcome and Introductions

Chairperson: Richard J. Auchus

12:05 PM TZ

Real Patient Journey

12:10 PM TZ

Interactive Patient Case Challenges

Pediatric/Adolescent Patients With CAH and Transition of Care

12:50 PM TZ

Panel Discussion and Q&A

TARGET AUDIENCE

This educational activity is intended for an audience of endocrinologists including adult and pediatric endocrinologists, pediatricians, nurse practitioners, and physician assistants.

GOAL STATEMENT

The goal of this activity is for learners to be better able to treat patients with CAH and have more timely diagnosis, pharmacologic management, and comprehensive care of pediatric and adolescent patients by exploring new therapeutic approaches and optimizing individualized treatment plans.

LEARNING OBJECTIVES

[bold]Upon completion of this activity, participants will:[/bold] [para]Have greater competence related to[/para] [list][item]Use of new therapeutic approaches for managing pediatric/adolescent patients with CAH [item]Comprehensive care in pediatric/adolescent patients with CAH[item]Timely diagnosis and management (including intensification or adjustment to pharmacologic management) in pediatric/adolescent patients with CAH [/list] [para]Demonstrate greater confidence in their ability to[/para] [list][item]Comprehensively manage CAH in the pediatric population [/list]

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[title]For Physicians[/title] [text]Medscape, LLC designates this live activity for a maximum of 1.0 [bold][italic]AMA PRA Category 1 Credit(s)[/italic][super]TM[/super][/bold]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.[/text]

An Interactive Case Study Approach for Pediatric Specialists CME